|
MMP7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.40759959244008E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.66410002128737E-09 |
| Normal-vs-Stage2 |
2.532000E-01 |
| Normal-vs-Stage3 |
9.52640000000393E-05 |
| Normal-vs-Stage4 |
4.377700E-02 |
| Stage1-vs-Stage2 |
2.058800E-01 |
| Stage1-vs-Stage3 |
4.180000E-02 |
| Stage1-vs-Stage4 |
2.051600E-01 |
| Stage2-vs-Stage3 |
1.142470E-02 |
| Stage2-vs-Stage4 |
1.060800E-01 |
| Stage3-vs-Stage4 |
6.980200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1988000309392E-10 |
| Normal-vs-AfricanAmerican |
4.264200E-02 |
| Normal-vs-Asian |
2.413400E-04 |
| Caucasian-vs-AfricanAmerican |
9.069600E-01 |
| Caucasian-vs-Asian |
3.677400E-03 |
| AfricanAmerican-vs-Asian |
2.860800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.324700E-03 |
| Normal-vs-Female |
2.67800004394303E-10 |
| Male-vs-Female |
9.019800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.40640000043402E-08 |
| Normal-vs-Age(41-60Yrs) |
2.576500E-04 |
| Normal-vs-Age(61-80Yrs) |
4.901100E-03 |
| Normal-vs-Age(81-100Yrs) |
3.797900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.533420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.148000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.228040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.581800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.098000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.774960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.584500E-02 |
| Classical-VS-Follicular |
8.19669998541883E-09 |
| Classical-VS-Other |
2.132800E-01 |
| Classical-VS-Normal |
1.49519999714798E-08 |
| Tall-VS-Follicular |
1.861040E-03 |
| Tall-VS-Other |
1.085690E-02 |
| Tall-VS-Normal |
1.941840E-03 |
| Follicular-VS-Other |
5.328200E-02 |
| Follicular-VS-Normal |
5.348000E-01 |
| Other-VS-Normal |
5.870400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.29039999999748E-05 |
| Normal-vs-N1 |
9.932000E-02 |
| N0-vs-N1 |
4.257400E-01 |
|
|
